Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Accumulated Depreciation (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Accumulated Depreciation for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation rose 35.47% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 35.47% year-over-year, with the annual reading at $1.2 million for FY2025, 35.47% up from the prior year.
  • Accumulated Depreciation for Q4 2025 was $1.2 million at Nuvation Bio, up from $874000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation was $1.2 million in Q4 2025, with the low at $666000.0 in Q4 2023.
  • Average Accumulated Depreciation over 3 years is $908000.0, with a median of $874000.0 recorded in 2024.
  • The sharpest move saw Accumulated Depreciation soared 31.23% in 2024, then surged 35.47% in 2025.
  • Over 3 years, Accumulated Depreciation stood at $666000.0 in 2023, then skyrocketed by 31.23% to $874000.0 in 2024, then surged by 35.47% to $1.2 million in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods came in at $1.2 million, $874000.0, and $666000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.